Neuropsychol Rev:认知干预是否可改善老年阿尔茨海默病患者的认知功能?

2022-06-09 MedSci原创 MedSci原创

阿尔茨海默病(AD)是一种退行性的神经系统疾病,会逐渐影响到记忆、执行功能、视觉空间能力、注意力和其他认知功能,是老年人中最常见的痴呆形式。

阿尔茨海默病(AD)是一种退行性的神经系统疾病,会逐渐影响到记忆、执行功能、视觉空间能力、注意力和其他认知功能,是老年人中最常见的痴呆形式。认知干预是一种重要的非药物干预类型,可以改善认知健康或有轻度障碍或痴呆的老年人的认知功能,包括认知训练、认知刺激和认知康复。近日,发表于Neuropsychol Rev的一项系统回顾重新评估了认知干预对AD患者的疗效。

这项回顾性研究最终纳入了20项研究(包括2012名参与者)。在全球认知功能方面,8项研究的综合平均差异(MD)为1.67(95%置信区间:0.45,2.89,p=0.007;Q=33.28,df=8,p<0.0001,τ2=2.17,I2=76%)。6项RCTs的集合标准化平均差异(SMD)在中期是1.61(95%置信区间:0.65,2.56,p = 0.0009;Q = 127.66,df = 6,p < 0.00001,τ2 = 1.56,I2 = 95%)。七项研究的汇总SMD在长期方面为0.79(95%置信区间:0.33, 1.25, p = 0.0008; Q = 35.10, df = 7, p < 0.0001, τ2 = 0.33, I2 = 80%)。对于抑郁症,两项试验的汇总SMD在短期内为-0.48(95%置信区间:-0.71,-0.24;p < 0.0001,I2 = 4%)。

综上所述,该研究结果表明,认知训练无论是在短期、中期还是长期干预后,都可能对全局认知功能有明显的改善,在短期干预后,对抑郁症也有明显的改善。然而,干预对总体认知功能或抑郁症的积极作用似乎在干预结束后并没有持续下去。目前仍缺乏与认知刺激和认知康复对观察结果、认知训练对记忆或其他非认知结果的影响有关的可靠和一致的结论。

原始出处:

Yun-Yun Wang, et al., The Effect of Cognitive Intervention on Cognitive Function in Older Adults With Alzheimer's Disease: A Systematic Review and Meta-Analysis.  Neuropsychol Rev. 2022 Jun;32(2):247-273. doi: 10.1007/s11065-021-09486-4.

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1817190, encodeId=4009181e190d2, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Thu Nov 24 14:38:10 CST 2022, time=2022-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818213, encodeId=ef54181821368, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jun 14 08:38:10 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241597, encodeId=f45a124159e1e, content=<a href='/topic/show?id=3cbe9e7892e' target=_blank style='color:#2F92EE;'>#阿尔茨海默病#</a><a href='/topic/show?id=254791214ad' target=_blank style='color:#2F92EE;'>#认知功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97789, encryptionId=3cbe9e7892e, topicName=阿尔茨海默病), TopicDto(id=91214, encryptionId=254791214ad, topicName=认知功能)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun Aug 28 15:18:42 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470562, encodeId=58ac14e05624f, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue May 31 10:38:10 CST 2022, time=2022-05-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1817190, encodeId=4009181e190d2, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Thu Nov 24 14:38:10 CST 2022, time=2022-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818213, encodeId=ef54181821368, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jun 14 08:38:10 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241597, encodeId=f45a124159e1e, content=<a href='/topic/show?id=3cbe9e7892e' target=_blank style='color:#2F92EE;'>#阿尔茨海默病#</a><a href='/topic/show?id=254791214ad' target=_blank style='color:#2F92EE;'>#认知功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97789, encryptionId=3cbe9e7892e, topicName=阿尔茨海默病), TopicDto(id=91214, encryptionId=254791214ad, topicName=认知功能)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun Aug 28 15:18:42 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470562, encodeId=58ac14e05624f, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue May 31 10:38:10 CST 2022, time=2022-05-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1817190, encodeId=4009181e190d2, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Thu Nov 24 14:38:10 CST 2022, time=2022-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818213, encodeId=ef54181821368, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jun 14 08:38:10 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241597, encodeId=f45a124159e1e, content=<a href='/topic/show?id=3cbe9e7892e' target=_blank style='color:#2F92EE;'>#阿尔茨海默病#</a><a href='/topic/show?id=254791214ad' target=_blank style='color:#2F92EE;'>#认知功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97789, encryptionId=3cbe9e7892e, topicName=阿尔茨海默病), TopicDto(id=91214, encryptionId=254791214ad, topicName=认知功能)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun Aug 28 15:18:42 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470562, encodeId=58ac14e05624f, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue May 31 10:38:10 CST 2022, time=2022-05-31, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1817190, encodeId=4009181e190d2, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Thu Nov 24 14:38:10 CST 2022, time=2022-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818213, encodeId=ef54181821368, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jun 14 08:38:10 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241597, encodeId=f45a124159e1e, content=<a href='/topic/show?id=3cbe9e7892e' target=_blank style='color:#2F92EE;'>#阿尔茨海默病#</a><a href='/topic/show?id=254791214ad' target=_blank style='color:#2F92EE;'>#认知功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97789, encryptionId=3cbe9e7892e, topicName=阿尔茨海默病), TopicDto(id=91214, encryptionId=254791214ad, topicName=认知功能)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun Aug 28 15:18:42 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470562, encodeId=58ac14e05624f, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue May 31 10:38:10 CST 2022, time=2022-05-31, status=1, ipAttribution=)]

相关威廉亚洲官网

上海大学蒋皆恢教授团队在阿尔茨海默病医学影像研究领域取得重要进展

阿尔茨海默病简称AD,目前我国AD患者已经超过1000万,AD前驱期患者数量占65岁以上老人比例超过30%,AD早期防治属国家重大战略需求。上海大学生物医学工程专业蒋皆恢教授团队长期从事AD医学影像研

BMJ:这几种健康生活方式,可以延长5年寿命,预防阿尔茨海默病

这项研究表明,健康的饮食、阅读、定期运动锻炼、不吸烟、限制饮酒这些健康的生活方式,与男性和女性更长的预期寿命有关,并且能够显著减少他们将来患阿尔茨海默病的风险。

European Radiology:QSM和VBM在阿尔茨海默病早期诊断的中的应用

现阶段,已有多项研究报道了关于QSM显示了AD或MCI患者脑实质中磁敏感强度的升高。

Alzheimers Res Ther:韩璎教授团队发现肠道菌群联合血浆Aβ可作为识别AD临床前期的潜在标记物

近日,由国家老年疾病临床医学研究中心(宣武医院)-中国AD临床前期联盟、首都医科大学宣武医院神经内科韩璎教授团队在国际学术期刊Alzheimers Research & Therapy发表题为

绿谷制药GV-971治疗阿尔茨海默病国际多中心III期临床停止

据Endpoints News报道,绿谷制药的阿尔茨海默病(AD)药物GV-971(甘露特钠胶囊,商品名:九期一)的国际III期临床试验已经停止。其中已有5家临床试验中心证实了该消息。

JNNP:血清GFAP鉴别阿尔茨海默病和额颞叶痴呆并预测MCI到痴呆的转化

反应性星形胶质细胞增生等神经炎症过程是包括阿尔茨海默病(AD)和额颞叶痴呆(FTD)在内的神经退行性痴呆的常见特征。在AD和FTD的死后脑组织和动物模型中发现了反应性星形胶质细胞,但它们在病理生理学中